ストックスクリーナーアプリを入手
3.98
1.79%
0.07
アフターアワーズ：
4.12
0.14
+3.52%
Aquestive Therapeutics Inc (AQST) 最新ニュース
Aquestive's Anaphylm to be reviewed by Health Canada - MSN
Chart based exit strategy for Aquestive Therapeutics Inc.July 2025 Short Interest & AI Powered Buy and Sell Recommendations - Newser
Analyzing recovery setups for Aquestive Therapeutics Inc. investorsQuarterly Market Summary & Daily Chart Pattern Signal Reports - Newser
Order flow analysis tools used on Aquestive Therapeutics Inc.Weekly Market Summary & Real-Time Price Movement Reports - Newser
Aquestive Therapeutics Inc. stock retracement – recovery analysisVolume Spike & Weekly Watchlist for Hot Stocks - Newser
Analyzing net buyer seller activity in Aquestive Therapeutics Inc.July 2025 Short Interest & Weekly Breakout Opportunity Watchlist - Newser
Unlocking Growth in Specialty Pharma: RTW Biotech's Strategic $75M Investment in Aquestive's Anaphylm - AInvest
Aquestive outlines patient-first Anaphylm launch strategy and maintains 2025 revenue guidance amid FDA review progress - MSN
$160m War Chest Readied For Aquestive’s Oral Epinephrine Film Launch - insights.citeline.com
Aquestive signs $75m agreement for launch of Anaphylm - Yahoo Finance
Evaluating Aquestive Therapeutics Inc. with trendline analysisJuly 2025 Trends & Weekly Return Optimization Alerts - Newser
Why Aquestive Therapeutics Inc. is moving today2025 Trading Recap & Fast Gaining Stock Strategy Reports - Newser
Technical analysis overview for Aquestive Therapeutics Inc. stockWeekly Market Report & Technical Pattern Based Signals - Newser
Earnings visualization tools for Aquestive Therapeutics Inc.CEO Change & Weekly Watchlist for Hot Stocks - Newser
Can Aquestive Therapeutics Inc. ride the EV waveQuarterly Performance Summary & Long-Term Safe Investment Ideas - thegnnews.com
Real time breakdown of Aquestive Therapeutics Inc. stock performanceQuarterly Investment Review & Free Expert Approved Momentum Trade Ideas - Newser
Understanding Aquestive Therapeutics Inc.’s price movementMarket Sentiment Report & Short-Term High Return Strategies - Newser
AQST FY2025 EPS Forecast Raised by Cantor Fitzgerald - Defense World
Will Aquestive Therapeutics Inc. price bounce be sustainablePortfolio Growth Summary & High Accuracy Swing Entry Alerts - Newser
Aquestive Therapeutics Inc. Forms Bullish Flag — Upside AheadMarket Sentiment Report & Accurate Trade Setup Notifications - metal.it
Is Aquestive Therapeutics Inc. stock entering bullish territoryEarnings Recap Summary & Reliable Price Action Trade Plans - Newser
Why Aquestive Therapeutics Inc. stock attracts strong analyst attention2025 Market Outlook & AI Forecasted Entry/Exit Points - Newser
Aquestive Therapeutics Announces $85M Stock Offering - MSN
How is Aquestive Therapeutics Inc. managing supply chain issues2025 Earnings Surprises & Free Growth Oriented Trading Recommendations - thegnnews.com
Pattern recognition hints at Aquestive Therapeutics Inc. upsideVolume Spike & Comprehensive Market Scan Insights - Newser
Leerink Partnrs Has Positive Forecast for AQST Q3 Earnings - Defense World
Aquestive Therapeutics rises after pricing $85M stock offering - MSN
Aquestive Therapeutics announces pricing of $85 million underwritten offering of shares - ROI-NJ
Aquestive Therapeutics: Advancing Anaphylm and Strategic Preparations Support Buy Rating - TipRanks
Published on: 2025-08-15 06:30:05 - newsyoung.net
Aquestive Therapeutics Second Quarter 2025 Earnings: EPS Beats Expectations, Revenues Lag - Yahoo Finance
Earnings Update: Aquestive Therapeutics, Inc. (NASDAQ:AQST) Just Reported And Analysts Are Trimming Their Forecasts - simplywall.st
Aquestive Therapeutics rises after $85 million stock sale - TradingView
Aquestive Therapeutics Announces $75M Strategic Funding - citybiz
Aquestive’s $85M offering and royalty deal; Basilea gets rights to UTI drug candidate - Endpoints News
Is Aquestive Therapeutics (AQST) Stock Outpacing Its Medical Peers This Year? - Yahoo Finance
Aquestive Therapeutics stock rises after securing $75 million funding deal By Investing.com - Investing.com Australia
Aquestive Therapeutics stock rises after securing $75 million funding deal - Investing.com
Aquestive Therapeutics Stock Is Rising Pre-Market – Its $75M Funding Agreement Draws Divided Opinions From Retail - Stocktwits
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Just Reported And Analysts Have Been Cutting Their Estimates - 富途牛牛
Aquestive Therapeutics Prices $85 Million Common Stock Offering - MarketScreener
Aquestive Therapeutics Secures $75M Funding for Anaphylm - TipRanks
Aquestive Therapeutics prices $85 million public offering By Investing.com - Investing.com Canada
Aquestive Therapeutics prices $85 million public offering - Investing.com India
Aquestive Therapeutics Secures $75 Million Funding Agreement with RTW - MarketScreener
Aquestive Therapeutics Announces Pricing of $85 Million Underwritten Offering of Common Stock - The Manila Times
Aquestive Therapeutics announces $75m strategic funding agreement with RTW - MarketScreener
Aquestive Secures $85M Backing to Launch Novel Sublingual Film for Severe Allergic Reactions - Stock Titan
First-Ever Oral Emergency Allergy Treatment Gets $75M Boost from RTW Investment - Stock Titan
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q2 2025 Earnings Call Transcript - Insider Monkey
Is it time to cut losses on Aquestive Therapeutics Inc.Weekly Profit Analysis & Daily Chart Pattern Signal Reports - Newser
XTX Topco Ltd Takes $228,000 Position in Aquestive Therapeutics, Inc. (NASDAQ:AQST) - Defense World
Aquestive Therapeutics Inc (AQST) Q2 2025 Earnings Call Highlights: Navigating Revenue ... By GuruFocus - Investing.com Canada
Aquestive Therapeutics Inc. Rebound Backed by Sentiment ShiftJuly 2025 Intraday Action & High Accuracy Swing Trade Signals - sundaytimes.kr
2.37%
0.37%
大文字化:
|
ボリューム (24 時間):